|
Für alle Interessierten: Mannkind und Receptor Life: Receptor’s dry powder inhalation technology, Receptor AIR\u2122, exclusively licensed from MannKind Corporation, resulted from Mr. Wesner’s experience as intellectual property counsel to MannKind. Mr. Wesner managed an exhaustive analysis of worldwide pulmonary drug delivery technologies and became convinced MannKind’s inhalation system is the only one capable of safely, reliably and precisely delivering cannabinoid-based drugs rapidly to the bloodstream. That insight led to Receptor and MannKind’s global partnership. Mehr unter: www.receptorlife.com |
|
| aus der Diskussion: | Mannkind, Game-Chancer in Sachen Diabetik? |
| Autor (Datum des Eintrages): | Magnetfeldfredy (30.10.18 07:14:10) |
| Beitrag: | 5,044 von 6,825 (ID:59089832) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |